Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the cancer-preventing shot quickly deflated last year, to the point the US ...

Merck & Co. (MRK) stock lost over 9% yesterday on announcing a temporary shipment halt of its Gardasil vaccine to China. The pharmaceutical giant’s CEO mentioned this in the Q4 earnings call ...

Merck reported Q4 sales and profit that beat Wall Street consensus. 2025 guidance was at least ~$2 billion below consensus. Shipments of Gardasil to China and a milestone payment on LM-299 are ...

Merck's 2025 revenue forecast fell short of Wall Street expectations, following the company's decision to temporarily halt shipments of its cancer vaccine, Gardasil, to China, CNBC reported Feb. 4.

Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations, as the company temporarily paused shipments of a key vaccine into China. Shares of Merck ...

The drugmaker plans to temporarily pause shipments of its Gardasil vaccine to China through at least the middle of the year. Merck gave no explanation in its fourth-quarter earnings report for the ...

The pause announcement comes a month after Merck received approval in China for use of the vaccine in males. “We believe China still represents a significant, long-term opportunity for Gardasil ...